Vision

eSTI2 aims

To reduce the clinical burden of STIs in the UK, impacting upon the £1 billion cost to the economy
Develop a unique partnership between Industry, Academia and the NHS, to build translational capacity in micro-diagnostic technologies
Develop, evaluate and facilitate polymicrobial point-of-care (PoC) and self-test mobile-phone networked micro-diagnostics
Create a diagnostic evaluation pipeline to enable industry easy access to clinical trials

eSTI2 will address key blocks to technology take up

Provide high-risk populations with easy and immediate access to diagnosis and treatment via smart-phone enabled diagnostics
Comprehensive and responsive STI surveillance
Tackle technological bottlenecks; provide the capacity to translate advances into validated commercial products
Advance the availability of polymicrobial testing
Address regulatory and ethical challenges
Investigate the health impact of telecommunication centred personalised STI diagnosis and management